Insider Buying: Imagion Biosystems Limited (ASX:IBX) Insider Acquires A$14,775.14 in Stock

Imagion Biosystems Limited (ASX:IBX) insider Brett Mitchell purchased 199,664 shares of Imagion Biosystems stock in a transaction that occurred on Friday, June 14th. The stock was purchased at an average cost of A$0.07 ($0.05) per share, for a total transaction of A$14,775.14 ($9,850.09).

Brett Mitchell also recently made the following trade(s):

• On Monday, June 17th, Brett Mitchell bought 91,551 shares of Imagion Biosystems stock. The shares were acquired at an average price of A$0.08 ($0.05) per share, for a total transaction of A$7,140.98 ($4,760.65).
• On Wednesday, June 19th, Brett Mitchell purchased 88,569 shares of Imagion Biosystems stock. The stock was acquired at an average price of A$0.09 ($0.06) per share, with a total value of A$7,971.21 ($5,314.14).

Imagion Biosystems Price Performance

The company has a quick ratio of 4.04, a current ratio of 0.11 and a debt-to-equity ratio of 98.44.

About Imagion Biosystems

Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer.